As of April 16, 2025, Nurix Therapeutics (NRIX) has a market cap of $0.75 billion USD. According to our data, Nurix Therapeutics is ranked No.5444 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $0.75 B |
-47.64%
|
Dec 31, 2024 | $1.43 B |
82.56%
|
Dec 29, 2023 | $0.78 B |
-6.01%
|
Dec 30, 2022 | $0.83 B |
-62.07%
|
Dec 31, 2021 | $2.20 B |
-11.95%
|
Dec 31, 2020 | $2.50 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Arvinas
ARVN
|
$0.52 B |
0.000 M
|
![]() USA
|
![]() Milestone Pharmaceuticals
MIST
|
$44.52 M |
-0.000 M
|
![]() Canada
|
![]() Kezar Life Sciences
KZR
|
$30.03 M |
0.000 M
|
![]() USA
|
![]() C4 Therapeutics
CCCC
|
$84.48 M |
0.000 M
|
![]() USA
|
![]() Allogene Therapeutics
ALLO
|
$0.32 B |
0.000 M
|
![]() USA
|
![]() Vir Biotechnology
VIR
|
$0.77 B |
-0.000 M
|
![]() USA
|
![]() Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
![]() USA
|
![]() Amgen
AMGN
|
$158.77 B |
0.132 B
|
![]() USA
|
![]() Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
![]() USA
|
![]() Merck
MRK
|
$197.26 B |
0.003 M
|
![]() USA
|
![]() Sanofi
SNY
|
$123.58 B |
-0.002 M
|
![]() France
|
![]() Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
![]() USA
|
Market Cap | = | NRIX Stock Price | * | NRIX Shares Outstanding |
= | $9.82 | * | 76.24 M | |
= | $0.75 B |